GHIRARDELLO, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 9.610
EU - Europa 1.305
AS - Asia 679
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 3
AF - Africa 2
SA - Sud America 2
Totale 11.613
Nazione #
US - Stati Uniti d'America 9.583
CN - Cina 618
IT - Italia 365
FI - Finlandia 250
DE - Germania 249
SE - Svezia 138
UA - Ucraina 132
GB - Regno Unito 110
VN - Vietnam 33
CA - Canada 27
IN - India 22
IE - Irlanda 19
FR - Francia 13
EU - Europa 12
NL - Olanda 10
RS - Serbia 4
RU - Federazione Russa 3
BD - Bangladesh 2
BE - Belgio 2
DZ - Algeria 2
NZ - Nuova Zelanda 2
SG - Singapore 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
PL - Polonia 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
Totale 11.613
Città #
Fairfield 1.545
Woodbridge 1.065
Houston 797
Chandler 793
Jacksonville 644
Ann Arbor 621
Ashburn 599
Seattle 559
Cambridge 557
Wilmington 553
Princeton 289
Beijing 149
San Diego 140
Nanjing 132
Des Moines 114
Medford 113
Roxbury 85
Helsinki 79
Padova 63
Boardman 57
Dearborn 51
New York 41
Shenyang 36
Hebei 34
Dong Ket 33
Nanchang 33
Jinan 28
Redwood City 27
Guangzhou 25
Jiaxing 25
Norwalk 25
Changsha 20
Milan 19
Ogden 16
Trois-Rivières 15
Rome 14
Tianjin 14
London 13
Kunming 12
Hefei 11
Kharkiv 11
Munich 11
Udine 10
Verona 10
Borås 9
Dublin 9
Düsseldorf 9
Falls Church 9
Tübingen 8
Washington 8
Detroit 6
Kilburn 6
Las Vegas 6
Los Angeles 6
Waterford 6
Genoa 5
Shanghai 5
Turin 5
Venice 5
Zhengzhou 5
Bussolengo 4
Ferrara 4
Florence 4
Grafing 4
Haikou 4
Islington 4
Lappeenranta 4
Palermo 4
Phoenix 4
Shreveport 4
Teramo 4
Trieste 4
Acton 3
Bari 3
Belgrade 3
Chongqing 3
Fuzhou 3
Genova 3
Hangzhou 3
Indiana 3
Kochi 3
Lanzhou 3
Ningbo 3
Ottawa 3
Simi Valley 3
Tappahannock 3
Vicenza 3
Windsor 3
Albino 2
Algiers 2
Amstelveen 2
Berlin 2
Bhopal 2
Brendola 2
Bresso 2
Bussero 2
Catanzaro 2
Chengdu 2
Cogorno 2
Como 2
Totale 9.715
Nome #
Gli anticorpi miosite specifici e miosite associati nelle miopatie infiammatorie idiopatiche: studio sierologico di 46 pazienti. 197
Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study 156
Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. 149
Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. 141
Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission 136
PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis. 130
Antigen preparation for immunological studies in systemic autoimmune diseases. 129
Autoinflammation and autoimmunity: Bridging the divide. 125
Antigen preparation for immunological studies in systemic autoimmune diseases 123
OxLDL/β2GPI-anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients. 120
Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity 119
Overlap connective tissue disease syndromes. 115
The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients 115
Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: A comprehensive review 114
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay 111
17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. 110
Polymyositis, dermatomyositis and malignancy: A further intriguing link. 108
Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Bechet disease 108
The olfactory function is impaired in patients with idiopathic inflammatory myopathies. 108
Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus 107
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 102
Prolonged remission in Caucasian patients with SLE: prevalence and outcomes 102
The clinical features, diagnosis and classification of dermatomyositis. 102
null 99
Cell stress-response in skeletal muscle myofibers 97
Clinical implications of autoantibody screening in patients with autoimmune myositis. 97
A catastrophic antiphospholipid syndrome: the importance of high levels of warfarin anticoagulation. 96
Polymyositis-dermatomyositis and infections. 96
Commercial blot assays in the diagnosis of systemic rheumatic diseases 95
Myositis autoantibodies and clinical phenotypes 95
Seltene autoimmune rheumatische erkrankungen in der schwangerschaft: systemische sklerose, dermato-polymyositis und vaskulitiden. 94
Cutting Edge Issues in Polymyositis 94
Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus 94
SLE diagnosis and treatment: When early is early 94
Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. 94
Polymyositis, dermatomyositis and malignancy: a further intriguing link 91
Overlap connective tissue disease syndromes. 91
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation 91
Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. 90
Emerging and critical issues in the pathogenesis of lupus. 89
Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus 88
Anti-ribosomal P protein antibodies and neuropsychiatric systemic lupus erythematosus: cross-sectional vs. prospective studies 88
Biological and clinical relevance of anti-prothrombin antibodies. 88
Long-term prognosis and causes of death in systemic lupus erythematosus 88
Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients 87
Anti-annexins autoantibodies: Their role as biomarkers of autoimmune diseases 85
High anti-golgi autoantibody levels: an early sign of autoimmune disease? 85
Long-term outcomes in difficult-to-treat patients with recurrent pericarditis 84
Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are theyspecific tools for the diagnosis of aPL syndrome? 84
Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block 82
Fibrinolytic pattern in recurrent spontaneous abortions: no relationship between hypofibrinolysis and anti-phospholipid antibodies. 81
Polymyositis, dermatomyositis and malignancy: a further intriguing link. 81
Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies 78
Autoantibodies in polymyositis and dermatomyositis. 78
SERPINB3 delays glomerulonephritis and attenuates the lupus-like disease in lupus murine models by inducing a more tolerogenic immune phenotype 78
New insights in myositis-specific autoantibodies 78
'Autoantibody dominance' pattern following idiotypicmanipulation of naive mice by immunization with anti-U1RNP antibodies. 76
The use of Tween 20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases 75
Autoantibodies in lupus: culprits or passive bystanders? 75
Infection as triggers and complication of sistemic lupus erythematosus 75
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus 74
Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry 74
Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age 73
Antiphospholipid antibodies in mixed connective tissue disease 73
Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant. 73
Cutting Edge Issues in Polymyositis 71
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus 70
Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis 70
Expression of myositis specific autoantigens during post-natal myogenesis 69
PREVALENCE AND CHARACTERISTICS OF ANTI-SINGLE-STRANDED DNA ANTIBODIES IN LOCALIZED SCLERODERMA - COMPARISON WITH SYSTEMIC LUPUS-ERYTHEMATOSUS 68
Antinuclear antibodies in recurrent idiopathic pericarditis: Prevalence and clinical significance 68
Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease 68
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 68
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis:. A prospective study of 100 women. 68
Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients 68
Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study 67
Diagnostic tests for antiribosomal P protein antibodies: a comparative evaluation of immunoblotting and ELISA assays 67
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 67
Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies. 66
Cutting Edge Issues in Polymyositis 66
Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus. 66
Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA) 66
Role of galectin-3 in autoimmune and non-autoimmune nephropathies 66
Effect of pregnancy on serum cytokines in SLE patients. 66
Th2 immune deviation induced by pregnancy: The two faces of autoimmune rheumatic diseases 64
Autoantibody profiles in the sera of European patients with myositis 62
Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients 61
Galectin-3 in autoimmunity and autoimmune diseases 61
Anti-PTX3 antibody: a new antibody in lupus. 60
Serpins, Immunity and Autoimmunity: Old Molecules, New Functions. 60
Health-related quality of life in Italian patients with systemic lupus erythematosus 58
The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays 58
DILAYED SYSTEMIC LUPUS ERYTHEMATOSUS SYMPTOMS AND INCREASED SURVIVAL BY SERPINB3 IN LUPUS-PRONE MICE 58
TNF-{alpha} is expressed in refractory skin lesions from subacute cutaneous lupus erythematosus patients. 57
Pregnancy in rheumatoid arteritis, Sjögren sindrome and other rare autoimmunerheumatic diseases. 56
Is C-reactive protein an useful tool in monitoring SLE pregnant women? 56
Clinical value of a peculiar nuclear fluorescence staining in systemicsclerosis. 56
Pentraxins, anti-pentraxins antibodies and atherosclerosis 56
Anti-Jo-1 antibodies. 54
Effect of coping skills on health-related quality of life in Italian SLE patients 54
Totale 8.641
Categoria #
all - tutte 36.816
article - articoli 34.224
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 83
patent - brevetti 0
selected - selezionate 0
volume - volumi 207
Totale 71.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019693 0 0 0 0 0 0 0 0 0 0 376 317
2019/20202.617 395 77 37 173 278 218 288 296 263 318 123 151
2020/20211.865 69 223 80 210 84 150 54 181 262 210 193 149
2021/20221.931 30 235 198 178 92 105 51 228 114 27 190 483
2022/20231.668 381 176 16 177 256 215 4 143 203 13 58 26
2023/2024744 38 112 112 81 95 100 64 52 52 34 4 0
Totale 11.725